CAN
XERS icon

Cetera Advisor Networks’s Xeris Biopharma Holdings XERS Stock Holding History

Cetera Advisor Networks’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$260K Buy
117,585
+595
+0.5% +$1.54K ﹤0.01% 2396
2023
Q4 		$275K Buy
116,990
+4,704
+4% +$8.68K ﹤0.01% 2302
2023
Q3 		$209K Buy
112,286
+1,449
+1% +$3.32K ﹤0.01% 2400
2023
Q2 		$290K Buy
110,837
+6,567
+6% +$16.7K ﹤0.01% 2109
2023
Q1 		$170K Buy
104,270
+19,894
+24% +$24.9K ﹤0.01% 2357
2022
Q4 		$112K Sell
84,376
-67
-0.1% -$95 ﹤0.01% 2366
2022
Q3 		$132K Sell
84,443
-33,047
-28% -$54.7K ﹤0.01% 1928
2022
Q2 		$181K Buy
117,490
+25,834
+28% +$54.5K ﹤0.01% 1883
2022
Q1 		$235K Buy
91,656
+6,281
+7% +$15.3K ﹤0.01% 1787
2021
Q4 		$250K Buy
+85,375
New +$184K ﹤0.01% 1726
2021
Q3 		– Sell
-44,740
Closed -$182K – 2057
2021
Q2 		$182K Buy
+44,740
New +$171K ﹤0.01% 1782

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Cetera Advisor Networks's XERS Position: Q1 2024 in Review

Cetera Advisor Networks increased its Xeris Biopharma Holdings (XERS) stake by 0.51% in Q1 2024, buying an estimated $1.54K and bringing the position to 117,585 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #2396.

Cetera Advisor Networks first reported a position in XERS in Q2 2021 and has held it in 11 quarters since. The position peaked at $290K in Q2 2023. 143 funds tracked by Wall St. Rank hold XERS as of Q1 2024.

  • Cetera Advisor Networks held 117,585 shares of Xeris Biopharma Holdings worth $260K as of Q1 2024.
  • Cetera Advisor Networks bought 595 Xeris Biopharma Holdings shares in Q1 2024, an estimated $1.54K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2396 holding.
  • Cetera Advisor Networks first reported a position in Xeris Biopharma Holdings in Q2 2021 and has held it in 11 quarters since.
  • Cetera Advisor Networks's Xeris Biopharma Holdings position peaked at $290K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.